The development team possess a range of essential expertise which we have brought to Mi-Trial.
- Professor Alex Horsley and Professor Jacky Smith are clinical academics who between them have led and designed dozens of clinical trials.
- ELAROS is a Sheffield-based developer of medical apps, already partnered with a number of different NHS organisations, who led the national roll-out of the C19-YRS long-covid symptom app. The platform was awarded funding for research use in 10 sites as part of the LOCOMOTION NIHR project, as well as being adopted by over 27 NHS Trusts across the UK.
Our collective experience therefore spans the full breadth of the trials process. We have built Mi-Trial to address the needs of patients and trials organisations, with specific objectives of helping patients improve trial adherence. This is a vital part of trial integrity: if a primary outcome is affected, this can cost potentially many thousands of pounds. The app was conceived to meet this need by being an essential aid to trial participants whilst the portal has been designed to cope with the full range of complex trial designs. These components have been brought together in a single, highly flexible, system which is easy to use and access.
Developed by clinical experts
The Mi-Trial team has input from NIHR Clinical Researchers, clinical academics, a trial organisation and a digital health company, to enhance the quality of our solution
Bespoke scheduling system
The Mi-Trial Portal allows trial sponsors or organisations to dynamically and intelligently configure a range of study structures thanks to a bespoke scheduling algorithm
100% Secure
Hosted on Amazon Web Services, Mi-Trial is a secure platform using 2-Factor Authentication (2FA) and other industry-leading cybersecurity standards
Improves quality of data
The restriction reminders and notifications in Mi-Trial reduce the number of erroneous or void study visits, improving study protocol adherence
